Ontogeny of cardiac β-adrenoceptor desensitization mechanisms: Agonist treatment enhances receptor/G-protein transduction rather than eliciting uncoupling

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 2, 1999, Pages 413-423

  Zeiders, J L ^a   Seidler, F J ^a   Iaccarino, G ^a   Koch, W J ^a   Slotkin, T A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adenylyl cyclase; Desensitization; Development of cardiac adrenoceptors and adenylyl cyclase; Heart, development of adrenoceptor signaling; Isoproterenol, effects on adrenoceptors and adenylyl cyclase; Adrenoceptor

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; GLUCAGON; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE;

ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DESENSITIZATION; HEART DEVELOPMENT; NEWBORN; NONHUMAN; ONTOGENY; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT; SYMPATHECTOMY;

EID: 0033084095     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0875     Document Type: Article

References (55)

1. Baxter RM, Secrist JP, Vaillancourt RR, Kazlauskas A, 1998. Full activation of the platelet-derived growth factor β-receptor kinase involves multiple events. J Biol Chem 273: 17050-17055.
2. s regulatory protein. Teratology 48: 169-177.
3. Bian X-P, Seidler FJ, Bartolome J, Kavlock RJ, Bartolome M, Slotkin TA, 1990. Dose-dependent effect of prenatal dexamethasone treatment on β-adrenergic receptor coupling to ornithine decarboxylase and cyclic AMP. J Dev Physiol 14: 125-130.
4. Bian X-P, Seidler FJ, Slotkin TA, 1992. Promotional role for glucocorticoids in the development of intracellular signalling: Enhanced cardiac and renal adenylate cyclase reactivity to β-adrenergic and non-adrenergic stimuli after low-dose fetal dexamethasone exposure. J Dev Physiol 17: 289-297.
5. 2+. Eur J Pharmacol 88: 269-272.
6. Choi DJ, Koch WJ, Hunter JJ, Rockman HA, 1997. Mechanism of β-adrenergic receptor desensitization in cardiac hypertrophy is increased β-adrenergic receptor kinase. J Biol Chem 272: 17223-17229.
7. Chuang TT, Salese M, Ambrosini G, Parruti G, De Blasi A, 1992. High expression of β-adrenergic receptor kinase in human peripheral blood lymphocytes: Isoproterenol and platelet activating factor can induce kinase translocation. J Biol Chem 267: 6886-6892.
8. Clark RB, Friedman J, Dixon RA, Strader CD, 1989. Identification of a specific site required for rapid heterologous desensitization of the β-adrenergic receptor by cAMP-dependent protein kinase. Mol Pharmacol 36: 343-348.
9. Conner DA, Mathier MA, Mortensen RM, Christe M, Vatner SF, Seidman CE, Seidman JG, 1997. β-arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to β-adrenergic stimulation. Circ Res 81: 1021-1026.
10. Gros GH, Chanez PO, Michel A, Boucard M, Serrano J-J, 1988. Post-natal evolution of rat cardiac beta-adrenoceptors. Life Sci 43: 699-706.
11. Giannuzzi CE, Seidler FJ, Slotkin TA, 1995. β-adrenoceptor control of cardiac adenylyl cyclase during development: Agonist pretreatment in the neonate uniquely causes heterologous sensitization, not desensitization. Brain Res 694: 271-278.
12. Gupta MP, Gupta M, Jakovcic S, Zak R, 1996. Catecholamines and cardiac growth. Mol Cell Biochem 164: 203-210.
13. Habib DM, Padbury JF, Martinez AM, Chappell BA, Thio SL, Burnell EE, 1991. Neonatal adaptation: Cardiac adrenergic effector mechanisms after birth in newborn sheep. Pediatr Res 29: 98-103.
14. Hausdorff WP, Caron MG, Lefkowitz RJ, 1990. Turning off the signal: Desensitization of β-adrenergic receptor function. FASEB J 4: 2881-2889.
15. Iaccarino G, Lefkowitz RJ, Koch WJ, 1997. Reciprocal regulation of myocardial βARK1 by adrenergic agonists and antagonists. Circ 96: I405.
16. Jaber M, Koch WJ, Rockman H, Smith B, Bond RA, Sulik KK, Ross J, Lefkowitz RJ, Caron MG, Giros B, 1996. Essential role of β-adrenergic receptor kinase 1 in cardiac development and function. Proc Nat Acad Sci 93: 12974-12979.
17. Johnson GL, Wolfe BB, Harden TK, Molinoff PB, Perkins JP, 1978. Role of β-adrenergic receptors in catecholamine-induced desensitization of adenylate cyclase in human astrocytoma cells. J Biol Chem 253: 1472-1480.
18. Karliner JS, Simpson PC, 1988. β-adrenoceptor and adenylate cyclase regulation in cardiac myocyte growth. Basic Res Cardiol 83: 655-663.
19. Kawai Y, Arinze IJ, 1993. Glucocorticoid regulation of G-protein subunits in neonatal liver. Mol Cell Endocrinol 90: 203-209.
20. Kenakin T, Morgan P, Lutz M, 1995. On the importance of the "antagonist assumption" to how receptors express themselves. Biochem Pharmacol 50: 17-26.
21. Koch WJ, Rockman HA, Samama P, Hamilton R, Bond RA, Milano CA, Lefkowitz RJ, 1995. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor. Science 268: 1350-1353.
22. Kudlacz EM, Navarro HA, Slotkin TA, 1989. Phosphatidic acid phosphatase in neonatal rat lung: Effects of prenatal dexamethasone or terbutaline treatment on basal activity and on responsiveness to beta adrenergic stimulation. J Pharmacol Exp Ther 250: 236-240.
23. Kudlacz EM, Navarro HA, Slotkin TA, 1990. Regulation of β-adrenergic receptor-mediated processes in fetal rat lung: Selective desensitization caused by chronic terbutaline exposure. J Dev Physiol 14: 103-108.
24. Kudlacz EM, Slotkin TA, 1990. Regulation of neonatal rat lung compliance by β-adrenergic receptor stimulation: Effects of prenatal exposure to terbutaline or dexamethasone. J Dev Physiol 14: 307-310.
25. Lagercrantz H, Slotkin TA, 1986. The "stress" of being born. Sci Amer 254: (April) 100-107.
26. Lau C, Burke SP, Slotkin TA, 1982. Maturation of sympathetic neurotransmission in the rat heart. IX. Development of transsynaptic regulation of cardiac adrenergic sensitivity. J Pharmacol Exp Ther 223: 675-680.
27. Lau C, Slotkin TA, 1980. Maturation of sympathetic neurotransmission in the rat heart. II. Enhanced development of presynaptic and postsynaptic components of noradrenergic synapses as a result of neonatal hyperthyroidism. J Pharmacol Exp Ther 212: 126-130.
28. Lau C, Slotkin TA, 1982. Maturation of sympathetic neurotransmission in the rat heart. VIII. Slowed development of noradrenergic synapses resulting from hypothyroidism. J Pharmacol Exp Ther 220: 629-636.
29. Maier JA, Roberts JM, Jacobs MM, 1989. Ontogeny of fetal adenylate cyclase; mechanisms for regulation of β-adrenergic receptors. J Dev Physiol 12: 249-261.
30. 1 and β-adrenergic receptors. Biochem Pharmacol 36: 1-6.
31. Navarro HA, Kudlacz EM, Kavlock RJ, Slotkin TA, 1991a. Prenatal terbutaline treatment: Tissue-selective dissociation of perinatal changes in β-adrenergic receptor binding from regulation of adenylate cyclase activity. Life Sci 48: 269-274.
32. Navarro HA, Kudlacz EM, Slotkin TA, 1991b. Control of adenylate cyclase activity in developing rat heart and liver: Effects of prenatal exposure to terbutaline or dexamethasone. Biol Neonate 60: 127-136.
33. 3 adenosine receptor. Mol Pharmacol 52: 632-640.
34. Ping PP, Gelzer-Bell R, Roth DA, Kiel D, Insel PA, Hammond HK, 1995. Reduced β-adrenergic receptor activation decreases G-protein expression and β-adrenergic receptor kinase activity in porcine heart. J Clin Invest 95: 1271-1280.
35. Pitcher JA, Inglese J, Higgins JB, Arriza JL, Casey PJ, Kim C, Benovic JL, Kwatra MM, Caron MG, Lefkowitz RJ, 1992. Role of βγ subunits of G proteins in targeting the β-adrenergic receptor kinase to membrane-bound receptors. Science 257: 1264-1267.
36. Pracyk JB, Lappi SE, Slotkin TA, 1991. Role of thyroid hormone in the development of beta adrenergic control of ornithine decarboxylase in rat heart and kidney. J Pharmacol Exp Ther 256: 757-766.
37. Pracyk JB, Slotkin TA, 1991. Thyroid hormone differentially regulates development of β-adrenergic receptors, adenylate cyclase and ornithine decarboxylase in rat heart and kidney. J Dev Physiol 16: 251-261.
38. Pracyk JB, Slotkin TA, 1992. Thyroid hormone regulates ontogeny of β-adrenergic receptors and adenylate cyclase in rat heart and kidney: Effects of propylthiouracil-induced perinatal hypothyroidism. J Pharmacol Exp Ther 261: 951-958.
39. s in heterologous desensitization: A role for adenosine 3′,5′-monophosphate-dependent phosphorylation. Endocrinology 131: 2774-2784.
40. Renick S, Seidler FJ, McCook EC, Slotkin TA, 1997. Neuronal control of cardiac and hepatic macromolecule synthesis in the neonatal rat: Effects of sympathectomy. Pediatr Res 41: 359-363.
41. Robkin MA, Shepard TH, Dyer DC, 1976. Autonomic receptors of the early rat embryo heart: Growth and development. Proc Soc Exp Biol Med 151: 799-803.
42. Schachat F, Seidler FJ, Slotkin TA, 1995. The developmental switch in ventricular myosin expression in vivo is not triggered by an increase in cyclic AMP. Reprod Fert Dev 7: 1361-1367.
43. Seidler FJ, Slotkin TA, 1979. Presynaptic and postsynaptic contributions to ontogeny of sympathetic control of heart rate in the preweanling rat. Brit J Pharmacol 65: 431-434.
44. Shear M, Insel PA, Melmon KL, Coffino P, 1976. Agonist-specific refractoriness induced by isoproterenol. J Biol Chem 251: 7572-7576.
45. Slotkin TA, 1986. Endocrine control of synaptic development in the sympathetic nervous system: The cardiac-sympathetic axis. In Developmental Neurobiology of the Autonomic Nervous System (Gootman PM, Ed.), pp. 97-133. Humana Press, Clifton, NJ.
46. Slotkin TA, Lau C, McCook EC, Lappi SE, Seidler FJ, 1994a. Glucocorticoids enhance intracellular signaling via adenylate cyclase at three distinct loci in the fetus: A mechanism for heterologous teratogenic sensitization? Toxicol Appl Pharmacol 127: 64-75.
47. Slotkin TA, Lau C, Seidler FJ, 1994b. β-adrenergic receptor overexpression in the fetal rat: Distribution, receptor subtypes and coupling to adenylate cyclase via G-proteins. Toxicol Appl Pharmacol 129: 223-234.
48. Slotkin TA, Lorber BA, McCook EC, Barnes GA, Seidler FJ, 1995. Neural input and the development of adrenergic intracellular signaling: Neonatal denervation evokes neither receptor upregulation nor persistent supersensitivity of adenylate cyclase. Dev Brain Res 88: 17-29.
49. Slotkin TA, Saleh JL, Zhang J, Seidler FJ, 1996. Ontogeny of β-adrenoceptor/adenylyl cyclase desensitization mechanisms: The role of neonatal innervation. Brain Res 742: 317-328.
50. Stein HM, Oyama K, Sapien R, Chappell BA, Padbury JF, 1992. Prolonged β-agonist infusion does not induce desensitization or down-regulation of β-adrenergic receptors in newborn sheep. Pediatr Res 31: 462-467.
51. Thai L, Galluzzo JM, McCook EC, Seidler FJ, Slotkin TA, 1996. Atypical regulation of hepatic adenylyl cyclase and adrenergic receptors during a critical developmental period: Agonists evoke supersensitivity accompanied by failure of receptor downregulation. Pediatr Res 39: 697-707.
52. Thomas JM, Huffman BB, 1996. Isoform-specific sensitization of adenylyl cyclase activity by prior activation of inhibitory receptors: Role of βγ subunits in transducing enhanced activity of the type VI isoform. Mol Pharmacol 49: 907-914.
53. h. J Mol Cell Cardiol 27: 2393-2396.
54. s-catalytic unit complex of adenylate cyclase in isoproterenol-induced heterologous desensitization. Eur J Pharmacol 159: 247-256.
55. Zeiders JL, Seidler FJ, Slotkin TA, 1997. Ontogeny of regulatory mechanisms for β-adrenoceptor control of rat cardiac adenylyl cyclase: Targeting of G-proteins and the cyclase catalytic subunit. J Mol Cell Cardiol 29: 603-615.